ORINASE DIAGNOSTIC Drug Patent Profile
✉ Email this page to a colleague
When do Orinase Diagnostic patents expire, and when can generic versions of Orinase Diagnostic launch?
Orinase Diagnostic is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in ORINASE DIAGNOSTIC is tolbutamide sodium. There are fifteen drug master file entries for this compound. Additional details are available on the tolbutamide sodium profile page.
Summary for ORINASE DIAGNOSTIC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Patent Applications: | 29 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORINASE DIAGNOSTIC at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ORINASE DIAGNOSTIC
US Patents and Regulatory Information for ORINASE DIAGNOSTIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | ORINASE DIAGNOSTIC | tolbutamide sodium | INJECTABLE;INJECTION | 012095-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |